OraSure Technologies | OSUR - Operating Expenses


OraSure Technologies reported $40.35M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bio Techne USD 226.2M 9.72M Jun/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
Dexcom USD 990.1M 53.5M Jun/2026
Illumina USD 525M 374M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 606.8M 39.4M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 604.27M 719K Sep/2026
STAAR Surgical USD 77.95M 5.48M Sep/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Trinity Biotech USD 12.63M 255K Mar/2026
Waters USD 527M 592M Jun/2026